PT1778655E - Derivados do ácido 2-{-3-2-(fenil)-oxazol-4-ilmetoxil- iclohexilmetoxi}- propiónico como ligandos de ppar (receptores activados pelos proliferadores de peroxisomas) para o tratamento de hiperlipidémia e diabetes - Google Patents
Derivados do ácido 2-{-3-2-(fenil)-oxazol-4-ilmetoxil- iclohexilmetoxi}- propiónico como ligandos de ppar (receptores activados pelos proliferadores de peroxisomas) para o tratamento de hiperlipidémia e diabetes Download PDFInfo
- Publication number
- PT1778655E PT1778655E PT05772240T PT05772240T PT1778655E PT 1778655 E PT1778655 E PT 1778655E PT 05772240 T PT05772240 T PT 05772240T PT 05772240 T PT05772240 T PT 05772240T PT 1778655 E PT1778655 E PT 1778655E
- Authority
- PT
- Portugal
- Prior art keywords
- hyperlipidaemie
- ylmethoxyl
- cyclohexylmethoxy
- oxazol
- diabetes
- Prior art date
Links
- 208000031226 Hyperlipidaemia Diseases 0.000 title 1
- 101150014691 PPARA gene Proteins 0.000 title 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 229940111131 antiinflammatory and antirheumatic product propionic acid derivative Drugs 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004039532A DE102004039532B4 (de) | 2004-08-14 | 2004-08-14 | Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1778655E true PT1778655E (pt) | 2009-07-13 |
Family
ID=35159900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT05772240T PT1778655E (pt) | 2004-08-14 | 2005-07-30 | Derivados do ácido 2-{-3-2-(fenil)-oxazol-4-ilmetoxil- iclohexilmetoxi}- propiónico como ligandos de ppar (receptores activados pelos proliferadores de peroxisomas) para o tratamento de hiperlipidémia e diabetes |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7956077B2 (pt) |
| EP (1) | EP1778655B1 (pt) |
| JP (1) | JP2008509891A (pt) |
| KR (1) | KR20070040813A (pt) |
| CN (1) | CN101031553A (pt) |
| AR (1) | AR050290A1 (pt) |
| AT (1) | ATE430739T1 (pt) |
| AU (1) | AU2005274492A1 (pt) |
| BR (1) | BRPI0513999A (pt) |
| CA (1) | CA2576545A1 (pt) |
| DE (2) | DE102004039532B4 (pt) |
| DK (1) | DK1778655T3 (pt) |
| ES (1) | ES2326423T3 (pt) |
| IL (1) | IL181010A0 (pt) |
| MX (1) | MX2007000913A (pt) |
| PE (1) | PE20060624A1 (pt) |
| PT (1) | PT1778655E (pt) |
| SV (1) | SV2006002191A (pt) |
| TW (1) | TW200619211A (pt) |
| UY (1) | UY29063A1 (pt) |
| WO (1) | WO2006018115A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ566877A (en) | 2005-09-29 | 2010-05-28 | Sanofi Aventis | Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE347890T1 (de) * | 2001-08-31 | 2007-01-15 | Sanofi Aventis Deutschland | Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
-
2004
- 2004-08-14 DE DE102004039532A patent/DE102004039532B4/de not_active Expired - Fee Related
-
2005
- 2005-07-30 MX MX2007000913A patent/MX2007000913A/es not_active Application Discontinuation
- 2005-07-30 ES ES05772240T patent/ES2326423T3/es active Active
- 2005-07-30 KR KR1020077003581A patent/KR20070040813A/ko not_active Application Discontinuation
- 2005-07-30 DE DE502005007249T patent/DE502005007249D1/de active Active
- 2005-07-30 WO PCT/EP2005/008281 patent/WO2006018115A1/de active Application Filing
- 2005-07-30 AU AU2005274492A patent/AU2005274492A1/en not_active Abandoned
- 2005-07-30 PT PT05772240T patent/PT1778655E/pt unknown
- 2005-07-30 BR BRPI0513999-6A patent/BRPI0513999A/pt not_active IP Right Cessation
- 2005-07-30 CN CNA2005800271498A patent/CN101031553A/zh active Pending
- 2005-07-30 JP JP2007525215A patent/JP2008509891A/ja not_active Abandoned
- 2005-07-30 CA CA002576545A patent/CA2576545A1/en not_active Abandoned
- 2005-07-30 DK DK05772240T patent/DK1778655T3/da active
- 2005-07-30 AT AT05772240T patent/ATE430739T1/de not_active IP Right Cessation
- 2005-07-30 EP EP05772240A patent/EP1778655B1/de not_active Not-in-force
- 2005-08-09 SV SV2005002191A patent/SV2006002191A/es unknown
- 2005-08-10 PE PE2005000924A patent/PE20060624A1/es not_active Application Discontinuation
- 2005-08-11 AR ARP050103351A patent/AR050290A1/es not_active Application Discontinuation
- 2005-08-11 TW TW094127242A patent/TW200619211A/zh unknown
- 2005-08-12 UY UY29063A patent/UY29063A1/es unknown
-
2007
- 2007-01-28 IL IL181010A patent/IL181010A0/en unknown
- 2007-02-06 US US11/671,673 patent/US7956077B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2576545A1 (en) | 2006-02-23 |
| PE20060624A1 (es) | 2006-07-27 |
| DK1778655T3 (da) | 2009-08-24 |
| SV2006002191A (es) | 2006-07-07 |
| DE502005007249D1 (de) | 2009-06-18 |
| JP2008509891A (ja) | 2008-04-03 |
| EP1778655B1 (de) | 2009-05-06 |
| DE102004039532A1 (de) | 2006-03-02 |
| US20070197613A1 (en) | 2007-08-23 |
| ATE430739T1 (de) | 2009-05-15 |
| DE102004039532B4 (de) | 2006-09-21 |
| KR20070040813A (ko) | 2007-04-17 |
| ES2326423T3 (es) | 2009-10-09 |
| AR050290A1 (es) | 2006-10-11 |
| US7956077B2 (en) | 2011-06-07 |
| BRPI0513999A (pt) | 2008-05-20 |
| IL181010A0 (en) | 2007-07-04 |
| MX2007000913A (es) | 2007-04-16 |
| AU2005274492A1 (en) | 2006-02-23 |
| TW200619211A (en) | 2006-06-16 |
| UY29063A1 (es) | 2006-02-24 |
| CN101031553A (zh) | 2007-09-05 |
| EP1778655A1 (de) | 2007-05-02 |
| WO2006018115A1 (de) | 2006-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL181009A0 (en) | N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl-succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes | |
| EP1740559A4 (en) | 1,3,5-SUBSTITUTED PHENYL DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| EP1807396A4 (en) | 2-AMINOPYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| EP1756040A4 (en) | PHENYL CARBOXAMIDE COMPOUNDS FOR USE AS BETA SECRETASE INHIBITORS IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
| IL175310A0 (en) | Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists | |
| IL195882A (en) | Crystalline forms of derivatives of (1 s) –1, 5 – anhydro – 1– c - (3 - ((phenyl) methyl) phenyl) - d -glucitol with amino acids and their use in the treatment of diabetes | |
| NO20054396D0 (no) | 3-metyl-2-(3-(2-fenyl-oksazol-4-ylmetoksy)-cykloheksankarbonyl-amino)-smorsyrederivater og lignende forbindelser som PPAR-modulatorer til behandling av type 2 diabetes og aterosklerose | |
| DE502006002956D1 (de) | Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung | |
| PT1638963E (pt) | Heterociclos de azoto n-acilado como ligandos de receptores activados pelo proliferador peroxissomal | |
| EP1720863A4 (en) | HETEROARYLAMINOPYRAZOLE DERIVATIVES FOR TREATING DIABETES | |
| SG130141A1 (en) | Modulation of peroxisome proliferator-activated receptors | |
| ZA200706294B (en) | Roflumilast for the treatment of diabetes mellitus | |
| WO2006127503A3 (en) | Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders | |
| JP2008506643A5 (ja) | 糖尿病の治療用の血糖値低下活性成分として使用するためのホスホチロシン・ホスファターゼ１ｂ(ｐｔｐ１ｂ)阻害剤としてのジフェニルアミン置換サリチルチアゾール誘導体及び関連化合物 | |
| ZA200710605B (en) | New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases | |
| ATE525355T1 (de) | 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1 | |
| SI1539746T1 (sl) | Spojine n-substituirane-1h-indol-5-propionske kisline kot agonisti ppar, ki so uporabne za zdravljenje diabetesa | |
| FR2848428B1 (fr) | Composition cosmetique et procede pour le traitement des matieres keratiniques, comprenant un compose photodimerisable | |
| EP1750698A4 (en) | 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES | |
| DE60318327D1 (de) | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe | |
| SG138604A1 (en) | Modulation of peroxisome proliferator-activated receptors | |
| PT1778655E (pt) | Derivados do ácido 2-{-3-2-(fenil)-oxazol-4-ilmetoxil- iclohexilmetoxi}- propiónico como ligandos de ppar (receptores activados pelos proliferadores de peroxisomas) para o tratamento de hiperlipidémia e diabetes | |
| NO20043483L (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av type 1 Diabetes mellitus | |
| DK1789402T3 (da) | 2-{-3-2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy)-propionsyrederivater som PPAR-ligander (peroxisomen-proliferator-aktiverede receptorer) til behandling af hyperlipidæmi og diabetes | |
| HU0600347D0 (en) | Process for the preparation of {2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidon) |